While the literature offers many hypotheses on the underlying mechanisms that explain why women are at a higher risk of LC, among the most cited are immunological variations, such as reduced pro-inflammatory interleukin-6 (IL-6) production following viral infection in women, which would explain their more lasting symptoms (27). The gene discussed is IL6; the disease is laryngotracheoesophageal cleft.